Company Filing History:
6 out of 6 
5 out of 5 
5 out of 5 Years Active: 2011-2025
Title: **Innovator Paul Warren Reddell: Pioneering Cancer Treatment and Infection Control**
Introduction
Paul Warren Reddell, located in Yungaburra, Australia, is a prolific inventor with a remarkable portfolio of 17 patents. His work primarily focuses on innovative methods to treat tumors and various infections, showcasing his dedication to advancing medical science and improving patient outcomes.
Latest Patents
Among his latest inventions is a patent related to the "Method of treating tumours," which involves the localized administration of an epoxytiglienone compound. This method aims to treat cancerous tumors through intratumoural or topical application, generating systemic anticancer effects. Another significant invention is centered around "Tiglien-3-one derivatives," which pertains to compounds designed to treat or prevent protozoal infections, bacterial infections, and parasitic infections, as well as to control pests affecting humans, animals, plants, and the environment.
Career Highlights
Throughout his career, Reddell has been associated with companies such as Qbiotics Pty Ltd and Ecobiotics Ltd. These affiliations have allowed him to align his innovative ideas with practical applications in the biotech sector, contributing to the development of groundbreaking therapies.
Collaborations
Reddell has also collaborated with notable individuals in his field, including Victoria Anne Gordon and Glen Mathew Boyle. Together, they have furthered research and practical applications of his innovative discoveries, demonstrating the power of teamwork in achieving significant advancements in medical technology.
Conclusion
Paul Warren Reddell stands out as a key player in the field of innovation, particularly in the areas of cancer treatment and infection management. His patents not only reflect his inventive spirit but also his commitment to enhancing health outcomes through scientific advancements. As his work continues to evolve, Reddell's contributions are poised to have a lasting impact in the medical and scientific communities.